About Imexpharm
Imexpharm is a publicly listed company based in Cao Lanh (Vietnam) founded in 1983, and was acquired by Livzon Pharmaceutical in May 2025. Diversified generic drugs are manufactured by Imexpharm in Vietnam. The company has 1,450 employees. Its website imexpharm.com draws about 21 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Công ty Cổ phần Dược phẩm Imexpharm.
Company details
Imexpharm was founded in 1983 and is based in Cao Lanh, Vietnam. Diversified generic drugs are produced by the company within the pharmaceutical sector. Operations focus on the development and manufacturing of various generic medications to address healthcare needs. Standard production processes are followed to ensure compliance with industry regulations. The companys domain, imexpharm.com, supports its online operations, with activities centered in Vietnam.
- Headquarters Cao Lanh, Vietnam
- Employees 1,450
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website imexpharm.com
- Social LinkedIn Facebook YouTube
- Acquired by Livzon Pharmaceutical (May 2025)
- Legal Name Imexpharm Corporation
- Annual Revenue$2440 B10.7as on Dec 31, 2025
- Net Profit$304.39 B2.3as on Dec 31, 2025
- EBITDA$567.15 B8.9as on Dec 31, 2025
- Latest Funding Round$8M (USD), Debt – Conventional
Dec 2020
- InvestorsSK
& 2 more
- Employee Count1,450
- Acquired by
Apps and channels of Imexpharm
its YouTube channel Imexpharm Corporation has 886 subscribers and 30 videos.
Videos from Imexpharm
The most watched videos on Imexpharm's YouTube channel, Imexpharm Corporation (886 subscribers). Click a video to play it here.
More on Imexpharm Corporation.
Funding Insights of Imexpharm
- Total Rounds 1
- Last Round Debt – Conventional — $8M
- First Round $8M
(Dec 2020)
- Investors Count 1
All 1 funding rounds of Imexpharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | $8M | Debt – Conventional | – | – |
3 investors in total: 3 institutional.
Investors in Imexpharm
Imexpharm has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include SK, Asian Development Bank and Livzon Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Advisory services and financial resources are mobilized for development projects. | 1966 | adb.org | Mandaluyong, Philippines | |
Manufacturer drug preparation, bulk medicines, and intermediates | 1985 | livzon.com.cn | Shanghai, China | |
Private equity firm focused on energy, chemical, semiconductor, logistics, and multiple sectors | 1953 | sk.com | Seoul, South Korea |
Investor details for Imexpharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Imexpharm
6 people are tracked at Imexpharm (3 in leadership, 3 in team); the tracked headcount is 1,450.
| Name | Role | Group |
|---|---|---|
Thi Tuong Vi Nguyen | Marketing Director | Leadership |
Nguyen Thu Hien | Head Of Communications | Leadership |
Dao Thi Tran | Chief Executive Officer | Leadership |
Hoa Nguyen | Legal Manager | Team |
Nhung le | Finance Manager | Team |
Khanh Hoang Tran | Product Manager | Team |
Complete people profiles for Imexpharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Imexpharm
Imexpharm is a publicly listed company on the HOSE with ticker symbol IMP in Vietnam, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date04 Dec 2006
- Listed onHSX: IMP
- Listed entityImexpharm Corporation
- Exchange sectorHealth technology
- ISINVN000000IMP0
- Share price36,600.00 VND (-0.95% on the day) · 2026-10-14
- Market capitalisation5,690,631,521,606.00 VND
- Price to earnings17.1
- EPS (diluted, trailing year)2,145.11 VND
- Dividend yield1.62%
- Volume (last session)6,235
Financials of Imexpharm
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 2,440.00B VND | 304.39B VND | 567.15B VND |
| 2024 | 2,210.00B VND | 297.54B VND | 520.79B VND |
| 2023 | 1,990.00B VND | 254.62B VND | 463.69B VND |
| 2022 | 1,640.00B VND | 196.72B VND | 356.89B VND |
| 2021 | 1,270.00B VND | 173.37B VND | 294.48B VND |
Detailed financial statements for Imexpharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Imexpharm
5 dated milestones of Imexpharm across 42 years, from founding to its latest funding, stage changes and deals.
- Founded Imexpharm is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $8.0M.
- Exit Acquired by SK.
- Exit Acquired by Livzon Pharmaceutical.
Web traffic of Imexpharm
The website of Imexpharm (imexpharm.com) receives about 20.8K visits a month.
- Monthly visits20.8K
▲ 38.4% vs previous month
Websites whose visitors overlap most with Imexpharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| domesco.com | 100% | 8.8K | #2,414,481 | View details | |
opcpharma.com | opcpharma.com | 100% | #662,390 | – | |
glomedvn.vn | glomedvn.vn | 99% | – | ||
| dhgpharma.com.vn | 95% | 54.5K | #528,694 | View details | |
bepharco.com | bepharco.com | 85% | #2,748,407 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Imexpharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Imexpharm
Imexpharm was founded in 1983 and raised its 1st funding round 37 years after it was founded.
Imexpharm is headquartered in Cao Lanh, Vietnam. It is registered at Cao Lanh, Measure, Vietnam.
Imexpharm has 1,450 employees.
Imexpharm was founded in 1983 and is based in Cao Lanh, Vietnam. Diversified generic drugs are produced by the company within the pharmaceutical sector. Operations focus on the development and manufacturing of various generic medications to address healthcare needs. Standard production processes are followed to ensure compliance with industry regulations. The companys domain, imexpharm.com, supports its online operations, with activities centered in Vietnam.
Yes, Imexpharm is publicly traded on HOSE under the ticker symbol IMP.
Imexpharm has 3 investors. Key investors include SK, Asian Development Bank, and Livzon Pharmaceutical.
Imexpharm operates through Công Ty Cổ Phần Dược Phẩm Imexpharm.
Yes. Imexpharm was acquired by Livzon Pharmaceutical in May 2025.